Your browser doesn't support javascript.
loading
Resolution Pharmacology: Focus on Pro-Resolving Annexin A1 and Lipid Mediators for Therapeutic Innovation in Inflammation.
Perretti, Mauro; Dalli, Jesmond.
Affiliation
  • Perretti M; The William Harvey Research Institute, Faculty of Medicine and Dentistry, and Centre for Inflammation and Therapeutic Innovation, Queen Mary University of London, London, United Kingdom; email: m.perretti@qmul.ac.uk, j.dalli@qmul.ac.uk.
  • Dalli J; The William Harvey Research Institute, Faculty of Medicine and Dentistry, and Centre for Inflammation and Therapeutic Innovation, Queen Mary University of London, London, United Kingdom; email: m.perretti@qmul.ac.uk, j.dalli@qmul.ac.uk.
Annu Rev Pharmacol Toxicol ; 63: 449-469, 2023 Jan 20.
Article in En | MEDLINE | ID: mdl-36151051
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Annexin A1 Limits: Humans Language: En Journal: Annu Rev Pharmacol Toxicol Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Annexin A1 Limits: Humans Language: En Journal: Annu Rev Pharmacol Toxicol Year: 2023 Type: Article